The Middle EAST Bioartificial Organ Manufacturing Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.20 billion by 2034, registering a CAGR of 10.00%. This growth trajectory is underpinned by several factors, including advancements in biotechnology, increasing prevalence of organ failures, and a rising demand for organ transplants. The region is witnessing a surge in...